Metraipolis › archive › dc_100174bd06af

Dissecting transcriptional amplification by MYC — Europe PMC PMID:32715994

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32715994
DOI
10.7554/elife.52483
License (as archived)
CC0-1.0
Archived
2026-11-08T00:26:08.628Z
SHA-256 of the archived text
ea3173705964d580ec741c8ced01cc17299776ea5617b410249fbcf3a4d63745
Stable URL of this page
https://metraipolis.com/documento/dc_100174bd06af

How to cite

Dissecting transcriptional amplification by MYC — Europe PMC PMID:32715994 — Europe PMC (en), https://europepmc.org/article/MED/32715994 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_100174bd06af (Metraipolis archive dc_100174bd06af, sha256 ea3173705964d580ec741c8ced01cc17299776ea5617b410249fbcf3a4d63745)
BibTeX
@misc{dc100174bd06af,
  title = {Dissecting transcriptional amplification by MYC — Europe PMC PMID:32715994},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32715994},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_100174bd06af; sha256 ea3173705964d580ec741c8ced01cc17299776ea5617b410249fbcf3a4d63745},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32715994. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Supraphysiological MYC levels are oncogenic. Originally considered a typical transcription factor recruited to E-boxes (CACGTG), another theory posits MYC a global amplifier increasing output at all active promoters. Both models rest on large-scale genome-wide "-omics'. Because the assumptions, statistical parameter and model choice dictates the '-omic' results, whether MYC is a general or specific transcription factor remains controversial. Therefore, an orthogonal series of experiments interrogated MYC's effect on the expression of synthetic reporters. Dose-dependently, MYC increased output at minimal promoters with or without an E-box. Driving minimal promoters with exogenous (glucocorticoid receptor) or synthetic transcription factors made expression more MYC-responsive, effectively increasing MYC-amplifier gain. Mutations of conserved MYC-Box regions I and II impaired amplification, whereas MYC-box III mutations delivered higher reporter output indicating that MBIII limits over-amplification. Kinetic theory and experiments indicate that MYC activates at least two steps in the transcription-cycle to explain the non-linear amplification of transcription that is essential for global, supraphysiological transcription in cancer.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: eLife, 2020 (prima pubblicazione 2020-07-27).
Identificativi: PMID 32715994 · PMCID PMC7384857 · DOI 10.7554/elife.52483.
Parole chiave degli autori: Human; Transcription; Cancer; MYC; systems biology; computational biology; Cancer Biology; Michaelis-menten Kinetics; General Amplifier; Kinetic Mechanism Of Action.
Descrittori MeSH principali: Gene Amplification; Transcriptional Activation.
Pagina: https://europepmc.org/article/MED/32715994 — https://doi.org/10.7554/elife.52483. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-08T00:23:12.624Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.